M
Medicus Pharma Ltd. (MDCX)
NCM – Real vaqt narxi. Valyuta: USD
0.32
-0.02 (-5.26%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.32
-0.02 (-5.26%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Medicus Pharma Ltd., biotexnologiya/hayot haqidagi fanlar kompaniyasi, Qo'shma Shtatlarda terapevtik aktivlarni klinik rivojlantirish dasturlarini ishlab chiqishga qaratilgan. U SKNJCT-003ni ishlab chiqmoqda, bu teri bazal hujayrali karsinomasi davolash uchun 2-bosqich tadqiqotida. Kompaniya Gorlin Sindromi Alyansi bilan Gorlin Sindromi bilan og'rigan bemorlarda SKINJECTga kirish uchun strategik hamkorlikni yo'lga qo'ygan. Kompaniya ilgari Interactive Capital Partners Corporation nomi bilan tanilgan va 2023 yil sentyabr oyida Medicus Pharma Ltd. nomini o'zgartirgan. Kompaniya 2008 yilda tashkil etilgan va Pensilvaniya shtatining Vest Konshoxoken shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Edward J. Brennan Jr., F.A.C.S., M.D. | Chief Scientific Officer and Head of R&D Program |
| Dr. Faisal Mehmud M.D. | Chief Medical Officer |
| Dr. Raza Bokhari M.B.A., M.D. | CEO & Executive Chairman |
| Mr. Andrew Alasdair Smith | Chief Operating Officer |
| Ms. Anna Baran-Djokovic J.D. | Senior Vice President of Investor Relations |
| Ms. Maryann Adesso | Chief of Staff & Corporate Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-04 | DEF 14A | formdef14a.htm |
| 2026-04-29 | 10-K/A | form10ka.htm |
| 2026-04-24 | 8-K | form8k.htm |
| 2026-04-21 | PRE 14A | formpre14a.htm |
| 2026-03-25 | POS AM | formposam.htm |
| 2026-03-06 | 8-K | form8k.htm |
| 2026-01-30 | S-3 | forms3.htm |
| 2026-01-30 | CORRESP | filename1.htm |
| 2026-01-12 | DRS | filename1.htm |
| 2025-12-10 | DRS | filename1.htm |
| Ms. Viktoria Slepeniuk | Senior Vice President of Public Relations |